Skip to main navigation
Editas Medicine
  • The DNA of Editas
    • Company Overview
    • Our Culture
    • Our Team
  • What is CRISPR?
  • Genome Editing
  • Our Programs
    • Areas of Research
    • Our Pipeline
    • Presentations & Publications
  • Be a Part of the Team
    • Community
    • Careers at Editas
  • Investors & Media
  • Contact

  • 02/06/19
    Summary ToggleEditas Medicine Names David Scadden, M.D., to Board of Directors
read more more news

Media & Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Annual Reports
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Investor FAQs
  • Information Request
  • Contact

SEC Filings

Form
10-Q
Filing Date
Aug 7, 2018
Document Date
Jun 30, 2018
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Editas Medicine
Issuer
Editas Medicine, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - EX-101.INS
EX-101.SCH - EX-101.SCH
EX-101.CAL - EX-101.CAL
EX-101.DEF - EX-101.DEF
EX-101.LAB - EX-101.LAB
EX-101.PRE - EX-101.PRE
           
Editas Medicine Logo Footer
  • The DNA of Editas
  • What is CRISPR?
  • Genome Editing
  • Our Programs
  • Be a Part of the Team
  • Investors & Media
  • Contact
  • Copyright © 2017 Editas Medicine
  • Terms of Use
  • Privacy Policy
Editas Medicine Logo Footer
  • Terms of Use
  • Privacy Policy
  • Contact
  • Copyright © 2017 Editas Medicine